Selected Financial Data
since 2005
Income Statement
Abiomed Inc., selected items from income statement, long-term trends
US$ in thousands
| 12 months ended: | Revenue | Income (loss) from operations | Net income (loss) |
|---|---|---|---|
| Mar 31, 2022 | 1,031,753) | 140,720) | 136,505) |
| Mar 31, 2021 | 847,522) | 229,557) | 225,525) |
| Mar 31, 2020 | 840,883) | 249,219) | 203,009) |
| Mar 31, 2019 | 769,432) | 224,812) | 259,016) |
| Mar 31, 2018 | 593,749) | 157,137) | 112,170) |
| Mar 31, 2017 | 445,304) | 90,138) | 52,116) |
| Mar 31, 2016 | 329,543) | 65,104) | 38,147) |
| Mar 31, 2015 | 230,311) | 28,666) | 113,688) |
| Mar 31, 2014 | 183,643) | 8,363) | 7,351) |
| Mar 31, 2013 | 158,124) | 16,543) | 15,014) |
| Mar 31, 2012 | 126,375) | 1,520) | 1,495) |
| Mar 31, 2011 | 101,151) | (11,185) | (11,755) |
| Mar 31, 2010 | 85,713) | (25,076) | (19,024) |
| Mar 31, 2009 | 73,210) | (29,518) | (31,597) |
| Mar 31, 2008 | 58,941) | (36,487) | (40,930) |
| Mar 31, 2007 | 50,649) | (28,511) | (27,881) |
| Mar 31, 2006 | 43,670) | (30,291) | (29,449) |
| Mar 31, 2005 | 38,216) | (3,253) | (2,342) |
Based on: 10-K (reporting date: 2022-03-31), 10-K (reporting date: 2021-03-31), 10-K (reporting date: 2020-03-31), 10-K (reporting date: 2019-03-31), 10-K (reporting date: 2018-03-31), 10-K (reporting date: 2017-03-31), 10-K (reporting date: 2016-03-31), 10-K (reporting date: 2015-03-31), 10-K (reporting date: 2014-03-31), 10-K (reporting date: 2013-03-31), 10-K (reporting date: 2012-03-31), 10-K (reporting date: 2011-03-31), 10-K (reporting date: 2010-03-31), 10-K (reporting date: 2009-03-31), 10-K (reporting date: 2008-03-31), 10-K (reporting date: 2007-03-31), 10-K (reporting date: 2006-03-31), 10-K (reporting date: 2005-03-31).
Balance Sheet: Assets
Abiomed Inc., selected items from assets, long-term trends
US$ in thousands
| Current assets | Total assets | |
|---|---|---|
| Mar 31, 2022 | 976,473) | 1,673,393) |
| Mar 31, 2021 | 787,965) | 1,494,359) |
| Mar 31, 2020 | 635,863) | 1,216,462) |
| Mar 31, 2019 | 677,197) | 1,054,346) |
| Mar 31, 2018 | 494,271) | 786,375) |
| Mar 31, 2017 | 326,958) | 550,414) |
| Mar 31, 2016 | 288,392) | 423,931) |
| Mar 31, 2015 | 220,139) | 338,367) |
| Mar 31, 2014 | 117,966) | 205,407) |
| Mar 31, 2013 | 116,605) | 169,999) |
| Mar 31, 2012 | 110,539) | 153,911) |
| Mar 31, 2011 | 84,737) | 131,588) |
| Mar 31, 2010 | 82,668) | 129,570) |
| Mar 31, 2009 | 88,489) | 135,958) |
| Mar 31, 2008 | 71,503) | 118,031) |
| Mar 31, 2007 | 96,382) | 136,183) |
| Mar 31, 2006 | 46,443) | 78,537) |
| Mar 31, 2005 | 55,224) | 61,061) |
Based on: 10-K (reporting date: 2022-03-31), 10-K (reporting date: 2021-03-31), 10-K (reporting date: 2020-03-31), 10-K (reporting date: 2019-03-31), 10-K (reporting date: 2018-03-31), 10-K (reporting date: 2017-03-31), 10-K (reporting date: 2016-03-31), 10-K (reporting date: 2015-03-31), 10-K (reporting date: 2014-03-31), 10-K (reporting date: 2013-03-31), 10-K (reporting date: 2012-03-31), 10-K (reporting date: 2011-03-31), 10-K (reporting date: 2010-03-31), 10-K (reporting date: 2009-03-31), 10-K (reporting date: 2008-03-31), 10-K (reporting date: 2007-03-31), 10-K (reporting date: 2006-03-31), 10-K (reporting date: 2005-03-31).
Balance Sheet: Liabilities and Stockholders’ Equity
Abiomed Inc., selected items from liabilities and stockholders’ equity, long-term trends
US$ in thousands
| Current liabilities | Total liabilities | Capital lease obligation | Stockholders’ equity | |
|---|---|---|---|---|
| Mar 31, 2022 | 138,457) | 170,067) | —) | 1,503,326) |
| Mar 31, 2021 | 128,969) | 164,684) | —) | 1,329,675) |
| Mar 31, 2020 | 131,885) | 150,996) | —) | 1,065,466) |
| Mar 31, 2019 | 105,998) | 117,456) | —) | 936,890) |
| Mar 31, 2018 | 84,682) | 96,851) | —) | 689,524) |
| Mar 31, 2017 | 69,617) | 98,343) | 16,338) | 452,071) |
| Mar 31, 2016 | 46,541) | 55,156) | —) | 368,775) |
| Mar 31, 2015 | 39,319) | 46,807) | —) | 291,560) |
| Mar 31, 2014 | 30,411) | 37,054) | —) | 168,353) |
| Mar 31, 2013 | 27,056) | 32,919) | —) | 137,080) |
| Mar 31, 2012 | 22,415) | 27,614) | —) | 126,297) |
| Mar 31, 2011 | 22,343) | 26,845) | —) | 104,743) |
| Mar 31, 2010 | 18,064) | 21,614) | —) | 107,956) |
| Mar 31, 2009 | 17,579) | 19,975) | —) | 115,983) |
| Mar 31, 2008 | 19,476) | 24,437) | —) | 93,594) |
| Mar 31, 2007 | 12,897) | 14,088) | —) | 122,095) |
| Mar 31, 2006 | 8,739) | 9,049) | —) | 69,488) |
| Mar 31, 2005 | 4,882) | 4,882) | —) | 56,179) |
Based on: 10-K (reporting date: 2022-03-31), 10-K (reporting date: 2021-03-31), 10-K (reporting date: 2020-03-31), 10-K (reporting date: 2019-03-31), 10-K (reporting date: 2018-03-31), 10-K (reporting date: 2017-03-31), 10-K (reporting date: 2016-03-31), 10-K (reporting date: 2015-03-31), 10-K (reporting date: 2014-03-31), 10-K (reporting date: 2013-03-31), 10-K (reporting date: 2012-03-31), 10-K (reporting date: 2011-03-31), 10-K (reporting date: 2010-03-31), 10-K (reporting date: 2009-03-31), 10-K (reporting date: 2008-03-31), 10-K (reporting date: 2007-03-31), 10-K (reporting date: 2006-03-31), 10-K (reporting date: 2005-03-31).
Cash Flow Statement
Abiomed Inc., selected items from cash flow statement, long-term trends
US$ in thousands
| 12 months ended: | Net cash provided by (used for) operating activities | Net cash (used for) provided by investing activities | Net cash provided by (used for) financing activities |
|---|---|---|---|
| Mar 31, 2022 | 285,390) | (380,990) | (2,202) |
| Mar 31, 2021 | 274,578) | (223,344) | (8,067) |
| Mar 31, 2020 | 314,920) | (125,455) | (117,715) |
| Mar 31, 2019 | 252,197) | (116,455) | (55,775) |
| Mar 31, 2018 | 192,546) | (180,762) | (9,137) |
| Mar 31, 2017 | 115,116) | (126,333) | 3,867) |
| Mar 31, 2016 | 76,795) | (57,710) | 7,160) |
| Mar 31, 2015 | 43,290) | (49,863) | 9,523) |
| Mar 31, 2014 | 23,466) | (22,272) | 9,632) |
| Mar 31, 2013 | 26,399) | (10,265) | (11,811) |
| Mar 31, 2012 | 3,634) | (17,480) | 14,680) |
| Mar 31, 2011 | 1,574) | (2,352) | 1,374) |
| Mar 31, 2010 | (7,362) | 8,818) | 979) |
| Mar 31, 2009 | (18,305) | (26,805) | 46,230) |
| Mar 31, 2008 | (28,874) | (40,905) | 2,070) |
| Mar 31, 2007 | (19,820) | 15,095) | 66,557) |
| Mar 31, 2006 | (9,339) | 7,369) | 2,093) |
| Mar 31, 2005 | (5,164) | 1,916) | 4,087) |
Based on: 10-K (reporting date: 2022-03-31), 10-K (reporting date: 2021-03-31), 10-K (reporting date: 2020-03-31), 10-K (reporting date: 2019-03-31), 10-K (reporting date: 2018-03-31), 10-K (reporting date: 2017-03-31), 10-K (reporting date: 2016-03-31), 10-K (reporting date: 2015-03-31), 10-K (reporting date: 2014-03-31), 10-K (reporting date: 2013-03-31), 10-K (reporting date: 2012-03-31), 10-K (reporting date: 2011-03-31), 10-K (reporting date: 2010-03-31), 10-K (reporting date: 2009-03-31), 10-K (reporting date: 2008-03-31), 10-K (reporting date: 2007-03-31), 10-K (reporting date: 2006-03-31), 10-K (reporting date: 2005-03-31).
Per Share Data
Abiomed Inc., selected data per share, long-term trends
US$
| 12 months ended: | Basic earnings per share 1 | Diluted earnings per share 2 | Dividend per share 3 |
|---|---|---|---|
| Mar 31, 2022 | 3.00 | 2.98 | 0.00 |
| Mar 31, 2021 | 5.00 | 4.94 | 0.00 |
| Mar 31, 2020 | 4.49 | 4.43 | 0.00 |
| Mar 31, 2019 | 5.77 | 5.61 | 0.00 |
| Mar 31, 2018 | 2.54 | 2.45 | 0.00 |
| Mar 31, 2017 | 1.21 | 1.17 | 0.00 |
| Mar 31, 2016 | 0.90 | 0.85 | 0.00 |
| Mar 31, 2015 | 2.80 | 2.65 | 0.00 |
| Mar 31, 2014 | 0.19 | 0.18 | 0.00 |
| Mar 31, 2013 | 0.38 | 0.37 | 0.00 |
| Mar 31, 2012 | 0.04 | 0.04 | 0.00 |
| Mar 31, 2011 | -0.32 | -0.32 | 0.00 |
| Mar 31, 2010 | -0.52 | -0.52 | 0.00 |
| Mar 31, 2009 | -0.91 | -0.91 | 0.00 |
| Mar 31, 2008 | -1.26 | -1.26 | 0.00 |
| Mar 31, 2007 | -1.03 | -1.03 | 0.00 |
| Mar 31, 2006 | -1.15 | -1.15 | 0.00 |
| Mar 31, 2005 | -0.11 | -0.11 | 0.00 |
Based on: 10-K (reporting date: 2022-03-31), 10-K (reporting date: 2021-03-31), 10-K (reporting date: 2020-03-31), 10-K (reporting date: 2019-03-31), 10-K (reporting date: 2018-03-31), 10-K (reporting date: 2017-03-31), 10-K (reporting date: 2016-03-31), 10-K (reporting date: 2015-03-31), 10-K (reporting date: 2014-03-31), 10-K (reporting date: 2013-03-31), 10-K (reporting date: 2012-03-31), 10-K (reporting date: 2011-03-31), 10-K (reporting date: 2010-03-31), 10-K (reporting date: 2009-03-31), 10-K (reporting date: 2008-03-31), 10-K (reporting date: 2007-03-31), 10-K (reporting date: 2006-03-31), 10-K (reporting date: 2005-03-31).
1, 2, 3 Data adjusted for splits and stock dividends.